Osteopenia Terminated Phase Trials for Risedronic acid (DB00884)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00145704Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone DensityTreatment